$VICR

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

Original reporting
Published Jul 21, 2026, 7:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 7:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth — source image
Decision brief

The 30-second read

$VICRBullishMed
01

Why it matters

The disclosed royalty payment schedule ($5M in year one, $10M in year two) and expected Q3 revenue recognition ($5M then $10M for four quarters) can affect revenue trajectory and investor confidence in recurring revenue. The fab discussion frames why a second fab is required to reach the $2.5B revenue target, linking demand to capacity constraints.

02

Market read

Traders can update near-term revenue expectations based on the stated royalty revenue recognition schedule and assess longer-term growth risk tied to second-fab execution.

03

What to watch

Lead times are said to extend slightly due to demand exceeding capacity, which could pressure shipments even if revenue recognition is supported by licensing and backlog growth.

Relevance 7/10Novelty 6/10Timing: during/after the Q2 2026 earnings call, ahead of Q3 revenue recognition updates

Background

The excerpt is from Vicor’s Q2 2026 earnings call Q&A, focusing on royalty license economics and manufacturing capacity expansion.

Company-level read

Ticker impact

$VICRBullishMedium confidence
Context

Vicor’s Q2 call discloses $5M quarterly royalty payments in year one and $10M in year two, contributing $15M to Q2 revenue.

Expected impact

Moderate upside bias if investors view the royalty stream and second-fab capacity as de-risking the path to higher revenue targets.

Evidence & confidence

The article provides specific royalty payment and revenue recognition schedules plus a capacity narrative (first fab near full capacity, second fab needed for $2.5B). That can change revenue quality expectations, though no explicit consensus beat/miss or new guidance number is provided beyond the described contribution.

Market effects

Signals ongoing demand for power delivery components tied to AI and industrial end markets, with capacity constraints influencing lead times.

No specific regional impact disclosed.

No explicit global macro or cross-border regulatory impacts disclosed.

Counterpoint

The royalty stream is described as GAAP revenue recognition separate from cash collections, so near-term earnings optics may not translate into immediate cash flow strength.

Key entities

  • Vicor Corp

    Subject of the earnings call highlights, including royalty license payments, revenue recognition timing, and fab capacity expansion plans.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ:

$VICRMedAI 8/10

Vicor (NASDAQ:VICR) Reaches New 12

Vicor (NASDAQ:VICR) reached a new 52-week high on Wednesday, trading up to $334.62 and last at $332.95 versus a prior close of $267.99, with 1,586,277 shares traded. The stock also followed its April 21 quarterly results: EPS $0.44 vs $0.40 expected; revenue $112.97M vs $109.05M. Analysts cited mixed ratings and targets.

$AEHRHighAI 9/10

Here's Why Aehr Test Systems Popped Higher Today

Aehr Test Systems shares rose about 16% on the day, after Vicor unexpectedly raised its second-quarter revenue guidance, according to Vicor. Vicor cited higher product revenues and royalties from an additional licensee. Aehr, which sells wafer-level burn-in test equipment for power semiconductors and AI processors, reported a $41M hyperscaler order, lifting orders to over $92M in fiscal 2026 H2.

$VICRMedAI 9/10

Vicor (NASDAQ:VICR) Shares Gap Up – Here’s Why

Vicor (NASDAQ:VICR) shares opened higher Tuesday after closing at $267.99 and opening at $296.45; last traded at $300.85 on volume of 242,290. The move followed recent analyst target changes, including Needham raising its price objective to $260 and Roth Mkm reaffirming $245. On April 21, Vicor reported Q1 EPS of $0.44 vs $0.40 expected and revenue of $112.97M vs $109.05M.